These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 14144501

  • 21. ON THE ROLE OF RIBOFLAVIN IN THE TERATOGENIC ACTIVITY OF BORIC ACID.
    LANDAUER W, CLARK EM.
    J Exp Zool; 1964 Aug; 156():307-12. PubMed ID: 14197067
    [No Abstract] [Full Text] [Related]

  • 22. [TERATOGENIC ACTION OF TISSUE HETERO-ANTIBODIES. II. STUDY OF THE TERATOGENIC ACTION OF ANTI-KIDNEY SERUMS IN THE MOUSE].
    MERCIER-PAROT L, DAVID G, TUCHMANN-DUPLESSIS H.
    C R Seances Soc Biol Fil; 1963 Oct 05; 157():974-7. PubMed ID: 14092119
    [No Abstract] [Full Text] [Related]

  • 23. [EXPERIMENTAL CONTRIBUTION TO THE TESTING OF TERATOGENIC DRUG EFFECTS IN THE LABORATORY RAT].
    BROCK N, VON KREYBIG.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Oct 13; 249():117-45. PubMed ID: 14345699
    [No Abstract] [Full Text] [Related]

  • 24. THE TERATOGENICITY OF CONGO RED IN RATS.
    BEAUDOIN AR.
    Proc Soc Exp Biol Med; 1964 Oct 13; 117():176-9. PubMed ID: 14219937
    [No Abstract] [Full Text] [Related]

  • 25. THE USE OF THALIDOMIDE AS TERATOGENIC AGENT IN RABBITS.
    DEKKER A, MEHRIZI A.
    Bull Johns Hopkins Hosp; 1964 Sep 13; 115():223-30. PubMed ID: 14209043
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [RESEARCH ON THE TERATOGENIC EFFECT OF 2-DIETHYLAMINOPROPIOPHENONE].
    CAHEN R, SAUTAI M, MONTAGNE J.
    Med Exp Int J Exp Med; 1964 Sep 13; 10():201-24. PubMed ID: 14173358
    [No Abstract] [Full Text] [Related]

  • 28. TERATOGENIC ACTION OF SALICYLATES RELATED TO THE INHIBITION OF MUCOPOLYSACCHARIDE SYNTHESIS.
    LARSSON KS, BOSTROEM H.
    Acta Paediatr Scand; 1965 Jan 13; 54():43-8. PubMed ID: 14248224
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. TERATOGENIC ACTION OF THALIDOMIDE.
    FELISATI D.
    Lancet; 1964 Mar 28; 1(7335):724-5. PubMed ID: 14107977
    [No Abstract] [Full Text] [Related]

  • 32. ACQUIRED CHROMOSOMAL ANOMALIES INDUCED IN MICE BY INJECTION OF A TERATOGEN IN PREGNANCY.
    INGALLS TH, INGENITO EF, CURLEY FJ.
    Science; 1963 Aug 30; 141(3583):810-2. PubMed ID: 14045134
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [TERATOGENESIS AS A PHARMACOLOGICAL-TOXICOLOGICAL PROBLEM. I. GENERAL FOUNDATIONS: NORMAL EMBRYOLOGICAL DEVELOPMENT OF RATS AND GUINEA PIGS].
    BROCK N, VON KREYBIG.
    Arzneimittelforschung; 1964 Jun 30; 14():655-64. PubMed ID: 14249062
    [No Abstract] [Full Text] [Related]

  • 38. [Principles and concepts of teratogenesis. I. The teratogenic injury (author's transl)].
    Rooze M.
    Rev Med Brux; 1980 Oct 30; 1(8):523-33. PubMed ID: 6781025
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.